Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FPNUS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,434
Award facts
- Contract value 100% obligated
- $88,433.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $88,433.60 on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens with a completion deadline of September 25, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio under the DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Mounjaro, a diabetes treatment medication, aligns with AmerisourceBergen's demonstrated capability in delivering endocrinology pharmaceuticals to military and federal health systems. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen competitively within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FPNUS?
SPE2DB25FPNUS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FPNUS worth?
The government has obligated $88,434 on SPE2DB25FPNUS.
Is contract SPE2DB25FPNUS an order under another contract?
Yes. SPE2DB25FPNUS is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNUS competed?
The extent of competition for SPE2DB25FPNUS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award